IL135564A0 - POLYCYCLIC α-AMINO-ɛ-CAPROLACTAMS AND RELATED COMPOUNDS - Google Patents

POLYCYCLIC α-AMINO-ɛ-CAPROLACTAMS AND RELATED COMPOUNDS

Info

Publication number
IL135564A0
IL135564A0 IL13556498A IL13556498A IL135564A0 IL 135564 A0 IL135564 A0 IL 135564A0 IL 13556498 A IL13556498 A IL 13556498A IL 13556498 A IL13556498 A IL 13556498A IL 135564 A0 IL135564 A0 IL 135564A0
Authority
IL
Israel
Prior art keywords
caprolactams
polycyclic
amino
related compounds
compounds
Prior art date
Application number
IL13556498A
Original Assignee
Elan Pharm Inc
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/996,422 external-priority patent/US6635632B1/en
Application filed by Elan Pharm Inc, Lilly Co Eli filed Critical Elan Pharm Inc
Publication of IL135564A0 publication Critical patent/IL135564A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18Dibenzazepines; Hydrogenated dibenzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
IL13556498A 1997-12-22 1998-10-29 POLYCYCLIC α-AMINO-ɛ-CAPROLACTAMS AND RELATED COMPOUNDS IL135564A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/996,422 US6635632B1 (en) 1996-12-23 1997-12-22 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US10272698A 1998-06-22 1998-06-22
PCT/US1998/022637 WO1999032453A1 (en) 1997-12-22 1998-10-29 POLYCYCLIC α-AMINO-⊂-CAPROLACTAMS AND RELATED COMPOUNDS

Publications (1)

Publication Number Publication Date
IL135564A0 true IL135564A0 (en) 2001-05-20

Family

ID=26799672

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13556498A IL135564A0 (en) 1997-12-22 1998-10-29 POLYCYCLIC α-AMINO-ɛ-CAPROLACTAMS AND RELATED COMPOUNDS

Country Status (9)

Country Link
EP (1) EP1042298A1 (en)
JP (1) JP2003521438A (en)
KR (1) KR20010033408A (en)
AU (1) AU1277799A (en)
BR (1) BR9812773A (en)
CA (1) CA2307221A1 (en)
HU (1) HUP0100294A3 (en)
IL (1) IL135564A0 (en)
WO (1) WO1999032453A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ525513A (en) 1998-08-07 2004-09-24 Pont Pharmaceuticals Du Succinoylamino lactams as inhibitors of Abeta protein production
BR9917082A (en) 1998-12-24 2001-11-06 Du Pont Pharm Co Compounds that inhibit the production of "beta" proteins, a method of treating neurological disorders associated with the production of "beta" -amyloid, pharmaceutical composition and, method of inhibiting y-secretase activity
EP1226139A2 (en) * 1999-07-06 2002-07-31 Vertex Pharmaceuticals Incorporated Cyclized amide derivatives for treating or preventing neuronal damage
MXPA02001813A (en) * 1999-09-13 2004-03-19 Bristol Myers Squibb Pharma Co Hydroxyalkanoyl aminolactams and related structures as inhibitors of a beta protein production.
US6503902B2 (en) 1999-09-13 2003-01-07 Bristol-Myers Squibb Pharma Company Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein production
US6960576B2 (en) 1999-09-13 2005-11-01 Bristol-Myers Squibb Pharma Company Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production
US6503901B1 (en) 1999-10-08 2003-01-07 Bristol Myers Squibb Pharma Company Amino lactam sulfonamides as inhibitors of Aβ protein production
JP2003523345A (en) 2000-02-17 2003-08-05 ブリストル−マイヤーズ スクイブ ファーマ カンパニー Succinoylamino carbocycles and heterocycles as inhibitors of Aβ protein production
CN1436175A (en) 2000-04-03 2003-08-13 布里斯托尔-迈尔斯斯奎布药品公司 Cyclic lactams as inhibitors of A beta-protein production
MXPA02009729A (en) 2000-04-03 2003-03-27 Bristol Myers Squibb Pharma Co CYCLIC LACTAMS AS INHIBITORS OF A beta PROTEIN PRODUCTION.
WO2001077086A1 (en) * 2000-04-11 2001-10-18 Dupont Pharmaceuticals Company SUBSTITUTED LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION
WO2001092235A1 (en) 2000-06-01 2001-12-06 Bristol-Myers Squibb Pharma Company LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
US6432944B1 (en) 2000-07-06 2002-08-13 Bristol-Myers Squibb Company Benzodiazepinone β-amyloid inhibitors: arylacetamidoalanyl derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666829A (en) * 1985-05-15 1987-05-19 University Of California Polypeptide marker for Alzheimer's disease and its use for diagnosis
DE69333144T2 (en) * 1992-10-26 2004-05-19 Elan Pharmaceuticals, Inc., San Francisco Method of identifying inhibitors of beta amyloid peptide production
NZ264143A (en) * 1993-08-09 1996-11-26 Lilly Co Eli Use of an aspartyl protease inhibitor to inhibit beta-amyloid peptide production
US5580979A (en) * 1994-03-15 1996-12-03 Trustees Of Tufts University Phosphotyrosine peptidomimetics for inhibiting SH2 domain interactions
US6251928B1 (en) * 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
BR9714517A (en) * 1996-12-23 2000-07-04 Elan Pharm Inc Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising them and processes to inhibit beta-amyloid peptide release and / or its synthesis by using such compounds
HRP980093A2 (en) * 1997-02-28 1998-12-31 Lilly Co Eli Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting "beta"-amyloid peptide release and/or its synthesis by use of such compounds

Also Published As

Publication number Publication date
CA2307221A1 (en) 1999-07-01
WO1999032453A1 (en) 1999-07-01
HUP0100294A2 (en) 2001-09-28
AU1277799A (en) 1999-07-12
JP2003521438A (en) 2003-07-15
EP1042298A1 (en) 2000-10-11
KR20010033408A (en) 2001-04-25
BR9812773A (en) 2000-10-10
HUP0100294A3 (en) 2003-04-28

Similar Documents

Publication Publication Date Title
EP1037635A4 (en) Compounds and methods
DE59803915D1 (en) Bandwaage
DE59806556D1 (en) Fmcw-sensor
DE59805100D1 (en) Containerbrücke
GB9702354D0 (en) Compounds and their use
DE59803341D1 (en) Handhobelmaschine
GB9705787D0 (en) Modified dendroaspins
HUP0100294A3 (en) Polycyclic alpha-amino-sigma-caprolactams and related compounds
HU9800057D0 (en) Bust-supporter
DE59803148D1 (en) Dimensionsstabile thermoplastische formmassen
HK1015814A1 (en) Azodyestuff mixtures
EP1001981A4 (en) Heregulin-like factor
EP1032559A4 (en) Aminoalkylphenol derivatives and related compounds
ZA988492B (en) Substituted tetrahydro-naphthalenes and analogous compounds
GB9821760D0 (en) Framelock component
GB2328633B (en) Wheelbrace
CA82218S (en) Sports-glasses
CA82745S (en) Handleset
CA79884S (en) Moniitor
CA82746S (en) Handleset
CA81694S (en) Tape-rule
CA80915S (en) Elbow-rest
CA80910S (en) Aeroglisseur
CA80851S (en) Thermomter
CA82333S (en) Remorque